drugset / Trial / NCT02714049

Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy

NCT02714049 ↗

Phase 4 Terminated 23 enrolled San Diego Sexual Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

Unblinded study of flibanserin for 8 weeks with responders randomized 1:1 to receive study medication alone vs. study medication and sex therapy for 12 additional weeks.

Timeline

Start
2017-01-25
Primary completion
2019-01-18
Completion
2019-01-30

Outcome

Outcome not reported

Stopped: “Investor Initiated Grant support stopped when drug was sold.”

Drugs

EvaluationDrugModalityDoseRoute
Subject flibanserin Small molecule — —